{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": [], "OtherAbstract": [], "KeywordList": [["arsenic", "atherosclerosis", "cardiovascular", "cigarette smoke", "endothelial dysfunction", "oxidative stress", "ozone", "particulate matter"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "29423456", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1016/j.cotox.2017.10.007"], "Journal": {"ISSN": "2468-2934", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2018", "Month": "Feb"}}, "Title": "Current opinion in toxicology", "ISOAbbreviation": "Curr Opin Toxicol"}, "ArticleTitle": "Unraveling mechanisms of toxicant-induced oxidative stress in cardiovascular disease.", "Pagination": {"StartPage": "1", "EndPage": "8", "MedlinePgn": "1-8"}, "Abstract": {"AbstractText": ["To date, numerous clinical studies examining correlations between oxidative stress biomarkers and cardiovascular diseases (CVD) have repeatedly suggested a role for oxidant injury in the pathogenesis of diseases such as atherosclerosis. Despite this, antioxidant supplementation trials have not demonstrated a reduction in disease progression. Nevertheless, small animal and epidemiological studies have linked exposures to certain toxicants with increased CVD risk involving putative oxidative stress mechanisms. A few prototypical vascular toxicants will be discussed as examples of toxicants that likely act via oxidative stress mechanisms. For discussion, we will classify these toxicants as those that induce direct (e.g., arsenic, nucleoside reverse transcriptase inhibitors) versus indirect (particulate matter, ozone) oxidative stress mechanisms, and those that likely induce CVD through both direct and indirect mechanisms (cigarette smoke). Finally, new findings in oxidative stress research, including the emerging importance of reactive sulfur species, hydrogen peroxide as a presumed endothelium-derived hyperpolarizing factors, etc., will be discussed, as well as the need to determine the role of toxicants in modulating these newly identified pathways. Moreover, given the lack of success in conclusively demonstrating the roles of oxidative stress in CVD risk stratification, research probing the roles of toxicant exposures in propagating CVD pathogenesis may be a novel approach for more conclusively delineating the causal role of oxidative stress in CVD initiation and progression."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Comparative Biomedical Sciences, LSU School of Veterinary Medicine, Skip Bertman Drive, Baton Rouge, LA 70803."}], "Identifier": [], "LastName": "Dugas", "ForeName": "Tammy R", "Initials": "TR"}], "GrantList": [{"GrantID": "P42 ES013648", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Curr Opin Toxicol", "NlmUniqueID": "101697847", "ISSNLinking": "2468-2020"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology. 2003;23(2):168\u2013175.", "ArticleIdList": ["12588755"]}, {"Citation": "Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: A review. Clinical cardiology. 1997;20(5):426\u2013432.", "ArticleIdList": ["PMC6656192", "9134272"]}, {"Citation": "Widlansky ME, Gokce N, Keaney JF, Jr, Vita JA. The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology. 2003;42(7):1149\u20131160.", "ArticleIdList": ["14522472"]}, {"Citation": "Porter NN. Prostaglandin endoperoxides. Academic Press; New York: 1980."}, {"Citation": "Sato R, Omura T. Cytochrome p450. Academic Press; New York: 1978."}, {"Citation": "Takeya R, Sumimoto H. Regulation of novel superoxide-producing nad(p)h oxidases. Antioxidants & redox signaling. 2006;8(9\u201310):1523\u20131532.", "ArticleIdList": ["16987008"]}, {"Citation": "Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford University Press; Oxford: 2015."}, {"Citation": "Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D. Formation of hydrogen peroxide and hydroxyl radicals from a(beta) and alpha-synuclein as a possible mechanism of cell death in alzheimer\u2019s disease and parkinson\u2019s disease. Free radical biology & medicine. 2002;32(11):1076\u20131083.", "ArticleIdList": ["12031892"]}, {"Citation": "Conn PM. Handbook of models for human aging. Elsevier; 2006."}, {"Citation": "Chen Q, Wang Q, Zhu J, Xiao Q, Zhang L. Reactive oxygen species: Key regulators in vascular health and diseases. British journal of pharmacology. 2017", "ArticleIdList": ["PMC5867026", "28430357"]}, {"Citation": "Denu JM, Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry. 1998;37(16):5633\u20135642.", "ArticleIdList": ["9548949"]}, {"Citation": "Parsons ZD, Gates KS. Redox regulation of protein tyrosine phosphatases: Methods for kinetic analysis of covalent enzyme inactivation. Methods in enzymology. 2013;528:129\u2013154.", "ArticleIdList": ["23849863"]}, {"Citation": "Godo S, Shimokawa H. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Free radical biology & medicine. 2017;109:4\u201310.", "ArticleIdList": ["27988339"]}, {"Citation": "Takaki A, Morikawa K, Murayama Y, Yamagishi H, Hosoya M, Ohashi J, Shimokawa H. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. Journal of cardiovascular pharmacology. 2008;52(6):510\u2013517.", "ArticleIdList": ["19034034"]}, {"Citation": "Gray SP, Di Marco E, Kennedy K, Chew P, Okabe J, El-Osta A, Calkin AC, Biessen EA, Touyz RM, Cooper ME, Schmidt HH, et al. Reactive oxygen species can provide atheroprotection via nox4-dependent inhibition of inflammation and vascular remodeling. Arteriosclerosis, thrombosis, and vascular biology. 2016;36(2):295\u2013307.", "ArticleIdList": ["26715682"]}, {"Citation": "Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, FitzGerald GA. Localization of distinct f2-isoprostanes in human atherosclerotic lesions. The Journal of clinical investigation. 1997;100(8):2028\u20132034.", "ArticleIdList": ["PMC508393", "9329967"]}, {"Citation": "Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coronary artery disease. 2003;14(3):213\u2013218.", "ArticleIdList": ["12702924"]}, {"Citation": "Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin f2alpha in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation. 1998;97(16):1536\u20131539.", "ArticleIdList": ["9593557"]}, {"Citation": "Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA. Increased formation of the isoprostanes ipf2alpha-i and 8-epi-prostaglandin f2alpha in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans. Circulation. 1997;96(10):3314\u20133320.", "ArticleIdList": ["9396422"]}, {"Citation": "Keaney JF, Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ, Framingham S. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the framingham study. Arteriosclerosis, thrombosis, and vascular biology. 2003;23(3):434\u2013439.", "ArticleIdList": ["12615693"]}, {"Citation": "Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, et al. In vivo formation of 8- iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin e supplementation. Circulation. 1999;99(2):224\u2013229.", "ArticleIdList": ["9892587"]}, {"Citation": "Reilly MP, Pratico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, FitzGerald GA. Increased formation of distinct f2 isoprostanes in hypercholesterolemia. Circulation. 1998;98(25):2822\u20132828.", "ArticleIdList": ["9860782"]}, {"Citation": "Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ., 2nd Increase in circulating products of lipid peroxidation (f2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. The New England journal of medicine. 1995;332(18):1198\u20131203.", "ArticleIdList": ["7700313"]}, {"Citation": "Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. Jama. 2001;286(17):2136\u20132142.", "ArticleIdList": ["11694155"]}, {"Citation": "Exner M, Minar E, Mlekusch W, Sabeti S, Amighi J, Lalouschek W, Maurer G, Bieglmayer C, Kieweg H, Wagner O, Schillinger M. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. Journal of the American College of Cardiology. 2006;47(11):2212\u20132218.", "ArticleIdList": ["16750686"]}, {"Citation": "Tretjakovs P, Jurka A, Bormane I, Mikelsone I, Elksne K, Krievina G, Reihmane D, Verbovenko J, Bahs G. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina. Clinica chimica acta; international journal of clinical chemistry. 2012;413(1\u20132):25\u201329.", "ArticleIdList": ["22024218"]}, {"Citation": "Kubala L, Lu G, Baldus S, Berglund L, Eiserich JP. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clinica chimica acta; international journal of clinical chemistry. 2008;394(1\u20132):59\u201362.", "ArticleIdList": ["PMC2474801", "18440308"]}, {"Citation": "Brevetti G, Schiano V, Laurenzano E, Giugliano G, Petretta M, Scopacasa F, Chiariello M. Myeloperoxidase, but not c-reactive protein, predicts cardiovascular risk in peripheral arterial disease. European heart journal. 2008;29(2):224\u2013230.", "ArticleIdList": ["18156137"]}, {"Citation": "Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and b vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. Jama. 2008;299(17):2027\u20132036.", "ArticleIdList": ["PMC2684623", "18460663"]}, {"Citation": "Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins c and e and beta carotene in the secondary prevention of cardiovascular events in women: Results from the women\u2019s antioxidant cardiovascular study. Archives of internal medicine. 2007;167(15):1610\u20131618.", "ArticleIdList": ["PMC2034519", "17698683"]}, {"Citation": "Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The su.Vi. Max study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Archives of internal medicine. 2004;164(21):2335\u20132342.", "ArticleIdList": ["15557412"]}, {"Citation": "Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, Malvy D, Paul-Dauphin A, Briancon S, Favier A. Background and rationale behind the su.Vi.Max study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Supplementation en vitamines et mineraux antioxydants study. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung Journal international de vitaminologie et de nutrition. 1998;68(1):3\u201320.", "ArticleIdList": ["9503043"]}, {"Citation": "Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, Touvier M, Favier A, Latino-Martel P, Briancon S, Galan P. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the su.Vi. Max study. International journal of cancer. 2010;127(8):1875\u20131881.", "ArticleIdList": ["20104528"]}, {"Citation": "Kelemen M, Vaidya D, Waters DD, Howard BV, Cobb F, Younes N, Tripputti M, Ouyang P. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: A substudy of the women\u2019s angiographic vitamin and estrogen (wave) trial. Atherosclerosis. 2005;179(1):193\u2013200.", "ArticleIdList": ["15721027"]}, {"Citation": "Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial. Jama. 2002;288(19):2432\u20132440.", "ArticleIdList": ["12435256"]}, {"Citation": "Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, Hercberg S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(8):1485\u20131491.", "ArticleIdList": ["15217803"]}, {"Citation": "Angelo G, Drake VJ, Frei B. Efficacy of multivitamin/mineral supplementation to reduce chronic disease risk: A critical review of the evidence from observational studies and randomized controlled trials. Critical reviews in food science and nutrition. 2015;55(14):1968\u20131991.", "ArticleIdList": ["24941429"]}, {"Citation": "Pastori D, Carnevale R, Pignatelli P. Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases? Internal and emergency medicine. 2014;9(2):123\u2013131.", "ArticleIdList": ["24057419"]}, {"Citation": "Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox biology. 2013;1:483\u2013491.", "ArticleIdList": ["PMC3830063", "24251116"]}, {"Citation": "Humans IWGotEoCRt. Arsenic, metals, fibres and dusts. No. 100C. International Agency for Research on Cancer; Lyon, FR: 2012."}, {"Citation": "States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci. 2009;107(2):312\u2013323.", "ArticleIdList": ["PMC2639760", "19015167"]}, {"Citation": "Ellinsworth DC. Arsenic, reactive oxygen, and endothelial dysfunction. The Journal of pharmacology and experimental therapeutics. 2015;353(3):458\u2013464.", "ArticleIdList": ["25788710"]}, {"Citation": "Kaur J, Reddy K, Balakumar P. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat. Cardiovascular toxicology. 2010;10(3):227\u2013238.", "ArticleIdList": ["20694523"]}, {"Citation": "Waghe P, Sarath TS, Gupta P, Kandasamy K, Choudhury S, Kutty HS, Mishra SK, Sarkar SN. Arsenic causes aortic dysfunction and systemic hypertension in rats: Augmentation of angiotensin ii signaling. Chemico-biological interactions. 2015;237:104\u2013114.", "ArticleIdList": ["26079204"]}, {"Citation": "Pi J, Horiguchi S, Sun Y, Nikaido M, Shimojo N, Hayashi T, Yamauchi H, Itoh K, Yamamoto M, Sun G, Waalkes MP, et al. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free radical biology & medicine. 2003;35(1):102\u2013113.", "ArticleIdList": ["12826260"]}, {"Citation": "Kesavan M, Sarath TS, Kannan K, Suresh S, Gupta P, Vijayakaran K, Sankar P, Kurade NP, Mishra SK, Sarkar SN. Atorvastatin restores arsenic-induced vascular dysfunction in rats: Modulation of nitric oxide signaling and inflammatory mediators. Toxicol Appl Pharmacol. 2014;280(1):107\u2013116.", "ArticleIdList": ["25058445"]}, {"Citation": "Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving hiv protease inhibitors. Aids. 1998;12(7):F51\u201358.", "ArticleIdList": ["9619798"]}, {"Citation": "Periard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V. Atherogenic dyslipidemia in hiv-infected individuals treated with protease inhibitors. The swiss hiv cohort study. Circulation. 1999;100(7):700\u2013705.", "ArticleIdList": ["10449690"]}, {"Citation": "Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with hiv nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome. Aids. 2000;14(3):F25\u201332.", "ArticleIdList": ["10716495"]}, {"Citation": "Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with hiv infection. Aids. 1999;13(18):2493\u20132505.", "ArticleIdList": ["10630518"]}, {"Citation": "Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nature medicine. 1995;1(5):417\u2013422.", "ArticleIdList": ["7585087"]}, {"Citation": "Jiang B, Hebert VY, Li Y, Mathis JM, Alexander JS, Dugas TR. Hiv antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis. Toxicol Appl Pharmacol. 2007;224(1):60\u201371.", "ArticleIdList": ["17669453"]}, {"Citation": "Lund KC, Wallace KB. Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics. Cardiovascular toxicology. 2004;4(3):217\u2013228.", "ArticleIdList": ["15470270"]}, {"Citation": "Lund KC, Wallace KB. Adenosine 3\u2032,5\u2032-cyclic monophosphate (camp)-dependent phosphoregulation of mitochondrial complex i is inhibited by nucleoside reverse transcriptase inhibitors. Toxicol Appl Pharmacol. 2008;226(1):94\u2013106.", "ArticleIdList": ["PMC2390784", "17904600"]}, {"Citation": "Glover M, Hebert VY, Nichols K, Xue SY, Thibeaux TM, Zavecz JA, Dugas TR. Overexpression of mitochondrial antioxidant manganese superoxide dismutase (mnsod) provides protection against azt- or 3tc-induced endothelial dysfunction. Antiviral research. 2014;111:136\u2013142.", "ArticleIdList": ["PMC4415438", "25260898"]}, {"Citation": "Wiest EF, Warneke A, Walsh MT, Langsfeld M, Anderson J, Walker MK. Association of serum aryl hydrocarbon receptor activity and rbc omega-3 polyunsaturated fatty acids with flow-mediated dilation in healthy, young hispanic cigarette smokers. Toxicol Lett. 2015;232(2):422\u2013428.", "ArticleIdList": ["PMC4335765", "25482063"]}, {"Citation": "Wiest EF, Walsh-Wilcox MT, Walker MK. Omega-3 polyunsaturated fatty acids protect against cigarette smoke-induced oxidative stress and vascular dysfunction. Toxicol Sci. 2017;156(1):300\u2013310.", "ArticleIdList": ["PMC6075584", "28115642"]}, {"Citation": "Yershova K, Yuan JM, Wang R, Valentin L, Watson C, Gao YT, Hecht SS, Stepanov I. Tobacco-specific n-nitrosamines and polycyclic aromatic hydrocarbons in cigarettes smoked by the participants of the shanghai cohort study. International journal of cancer. 2016;139(6):1261\u20131269.", "ArticleIdList": ["PMC5152590", "27163125"]}, {"Citation": "Reddy S, Finkelstein EI, Wong PS, Phung A, Cross CE, van der Vliet A. Identification of glutathione modifications by cigarette smoke. Free radical biology & medicine. 2002;33(11):1490\u20131498.", "ArticleIdList": ["12446206"]}, {"Citation": "Kopf PG, Scott JA, Agbor LN, Boberg JR, Elased KM, Huwe JK, Walker MK. Cytochrome p4501a1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci. 2010;117(2):537\u2013546.", "ArticleIdList": ["PMC2940412", "20634294"]}, {"Citation": "Conklin DJ, Haberzettl P, Prough RA, Bhatnagar A. Glutathione-s-transferase p protects against endothelial dysfunction induced by exposure to tobacco smoke. American journal of physiology Heart and circulatory physiology. 2009;296(5):H1586\u20131597.", "ArticleIdList": ["PMC2685347", "19270193"]}, {"Citation": "Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, et al. Cigarette smoking and variations in systemic immune and inflammation markers. Journal of the National Cancer Institute. 2014;106(11)", "ArticleIdList": ["PMC4200029", "25274579"]}, {"Citation": "Kim M, Han CH, Lee MY. Nadph oxidase and the cardiovascular toxicity associated with smoking. Toxicological research. 2014;30(3):149\u2013157.", "ArticleIdList": ["PMC4206741", "25343008"]}, {"Citation": "Wada T, Sunaga H, Ohkawara R, Shimba S. Aryl hydrocarbon receptor modulates nadph oxidase activity via direct transcriptional regulation of p40phox expression. Molecular pharmacology. 2013;83(5):1133\u20131140.", "ArticleIdList": ["23478803"]}, {"Citation": "Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103(23):2810\u20132815.", "ArticleIdList": ["11401937"]}, {"Citation": "Wellenius GA, Burger MR, Coull BA, Schwartz J, Suh HH, Koutrakis P, Schlaug G, Gold DR, Mittleman MA. Ambient air pollution and the risk of acute ischemic stroke. Archives of internal medicine. 2012;172(3):229\u2013234.", "ArticleIdList": ["PMC3639313", "22332153"]}, {"Citation": "Kloog I, Nordio F, Zanobetti A, Coull BA, Koutrakis P, Schwartz JD. Short term effects of particle exposure on hospital admissions in the mid-atlantic states: A population estimate. PloS one. 2014;9(2):e88578.", "ArticleIdList": ["PMC3917892", "24516670"]}, {"Citation": "Pope CA, 3rd, Dockery DW. Health effects of fine particulate air pollution: Lines that connect. Journal of the Air & Waste Management Association. 2006;56(6):709\u2013742.", "ArticleIdList": ["16805397"]}, {"Citation": "Cesaroni G, Forastiere F, Stafoggia M, Andersen ZJ, Badaloni C, Beelen R, Caracciolo B, de Faire U, Erbel R, Eriksen KT, Fratiglioni L, et al. Long term exposure to ambient air pollution and incidence of acute coronary events: Prospective cohort study and meta-analysis in 11 european cohorts from the escape project. Bmj. 2014;348:f7412.", "ArticleIdList": ["PMC3898420", "24452269"]}, {"Citation": "Li W, Wilker EH, Dorans KS, Rice MB, Schwartz J, Coull BA, Koutrakis P, Gold DR, Keaney JF, Jr, Lin H, Vasan RS, et al. Short-term exposure to air pollution and biomarkers of oxidative stress: The framingham heart study. J Am Heart Assoc. 2016;5(5)", "ArticleIdList": ["PMC4889166", "27126478"]}, {"Citation": "dela Cruz AL, Gehling W, Lomnicki S, Cook R, Dellinger B. Detection of environmentally persistent free radicals at a superfund wood treating site. Environmental science & technology. 2011;45(15):6356\u20136365.", "ArticleIdList": ["PMC3167238", "21732664"]}, {"Citation": "Dugas TR, Lomnicki S, Cormier SA, Dellinger B, Reams M. Addressing emerging risks: Scientific and regulatory challenges associated with environmentally persistent free radicals. International journal of environmental research and public health. 2016;13(6)", "ArticleIdList": ["PMC4924030", "27338429"]}, {"Citation": "Squadrito GL, Cueto R, Dellinger B, Pryor WA. Quinoid redox cycling as a mechanism for sustained free radical generation by inhaled airborne particulate matter. Free radical biology & medicine. 2001;31(9):1132\u20131138.", "ArticleIdList": ["11677046"]}, {"Citation": "Valavanidis A, Fiotakis K, Vlahogianni T, Papadimitriou V, Pantikaki V. Determination of selective quinones and quinoid radicals in airborne particulate matter and vehicular exhaust particles (vol 3, pg 118, 2006) Environ Chem. 2006;3(3):233\u2013U212."}, {"Citation": "Valavanidis A, Iliopoulos N, Gotsis G, Fiotakis K. Persistent free radicals, heavy metals and pahs generated in particulate soot emissions and residue ash from controlled combustion of common types of plastic. Journal of hazardous materials. 2008;156(1\u20133):277\u2013284.", "ArticleIdList": ["18249066"]}, {"Citation": "Valavanidis A, Vlahoyianni T, Fiotakis K. Comparative study of the formation of oxidative damage marker 8-hydroxy-2\u2032-deoxyguanosine (8-ohdg) adduct from the nucleoside 2\u2032-deoxyguanosine by transition metals and suspensions of particulate matter in relation to metal content and redox reactivity. Free radical research. 2005;39(10):1071\u20131081.", "ArticleIdList": ["16298732"]}, {"Citation": "Yang L, Liu G, Zheng M, Jin R, Zhu Q, Zhao Y, Wu X, Xu Y. Highly elevated levels and particle-size distributions of environmentally persistent free radicals in haze-associated atmosphere. Environmental science & technology. 2017;51(14):7936\u20137944.", "ArticleIdList": ["28613843"]}, {"Citation": "Kelley MA, Hebert VY, Thibeaux TM, Orchard MA, Hasan F, Cormier SA, Thevenot PT, Lomnicki SM, Varner KJ, Dellinger B, Latimer BM, et al. Model combustion-generated particulate matter containing persistent free radicals redox cycle to produce reactive oxygen species. Chemical research in toxicology. 2013;26(12):1862\u20131871.", "ArticleIdList": ["PMC4112599", "24224526"]}, {"Citation": "Khachatryan L, Vejerano E, Lomnicki S, Dellinger B. Environmentally persistent free radicals (epfrs). 1. Generation of reactive oxygen species in aqueous solutions. Environmental science & technology. 2011;45(19):8559\u20138566.", "ArticleIdList": ["PMC3230252", "21823585"]}, {"Citation": "Lord K, Moll D, Lindsey JK, Mahne S, Raman G, Dugas T, Cormier S, Troxlair D, Lomnicki S, Dellinger B, Varner K. Environmentally persistent free radicals decrease cardiac function before and after ischemia/reperfusion injury in vivo. Journal of receptor and signal transduction research. 2011;31(2):157\u2013167.", "ArticleIdList": ["PMC3152960", "21385100"]}, {"Citation": "Thevenot PT, Saravia J, Jin N, Giaimo JD, Chustz RE, Mahne S, Kelley MA, Hebert VY, Dellinger B, Dugas TR, Demayo FJ, et al. Radical-containing ultrafine particulate matter initiates epithelial-to-mesenchymal transitions in airway epithelial cells. American journal of respiratory cell and molecular biology. 2013;48(2):188\u2013197.", "ArticleIdList": ["PMC3604062", "23087054"]}, {"Citation": "Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105(13):1534\u20131536.", "ArticleIdList": ["11927516"]}, {"Citation": "Chuang GC, Yang Z, Westbrook DG, Pompilius M, Ballinger CA, White CR, Krzywanski DM, Postlethwait EM, Ballinger SW. Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Physiol Lung Cell Mol Physiol. 2009;297(2):L209\u2013216.", "ArticleIdList": ["PMC2742788", "19395667"]}, {"Citation": "Pryor WA, Squadrito GL, Friedman M. A new mechanism for the toxicity of ozone. Toxicol Lett. 1995;82\u201383:287\u2013293.", "ArticleIdList": ["8597067"]}, {"Citation": "Robertson S, Colombo ES, Lucas SN, Hall PR, Febbraio M, Paffett ML, Campen MJ. Cd36 mediates endothelial dysfunction downstream of circulating factors induced by o3 exposure. Toxicol Sci. 2013;134(2):304\u2013311.", "ArticleIdList": ["PMC3707435", "23650127"]}, {"Citation": "Olson KR, Gao Y, DeLeon ER, Arif M, Arif F, Arora N, Straub KD. Catalase as a sulfide-sulfur oxido-reductase: An ancient (and modern?) regulator of reactive sulfur species (rss) Redox biology. 2017;12:325\u2013339.", "ArticleIdList": ["PMC5350573", "28285261"]}, {"Citation": "Filipovic MR. Persulfidation (s-sulfhydration) and h2s. Handbook of experimental pharmacology. 2015;230:29\u201359.", "ArticleIdList": ["26162828"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "2", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29423456", "NIHMS912624", "PMC5798618", "10.1016/j.cotox.2017.10.007"]}}]}